186 related articles for article (PubMed ID: 35012658)
1. Puromycin-based purification of cells with high expression of the cytochrome P450 CYP3A4 gene from a patient with drug-induced liver injury (DILI).
Miyata S; Saku N; Akiyama S; Javaregowda PK; Ite K; Takashima N; Toyoda M; Yura K; Kimura T; Nishina H; Nakazawa A; Kasahara M; Nonaka H; Kiyono T; Umezawa A
Stem Cell Res Ther; 2022 Jan; 13(1):6. PubMed ID: 35012658
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
3. Study Liver Cytochrome P450 3A4 Inhibition and Hepatotoxicity Using DMSO-Differentiated HuH-7 Cells.
Liu Y
Methods Mol Biol; 2022; 2474():39-46. PubMed ID: 35294754
[TBL] [Abstract][Full Text] [Related]
4. Drug metabolic activity is a critical cell-intrinsic determinant for selection of hepatocytes during long-term culture.
Akiyama S; Saku N; Miyata S; Ite K; Toyoda M; Kimura T; Kuroda M; Nakazawa A; Kasahara M; Nonaka H; Kamiya A; Kiyono T; Kobayshi T; Murakami Y; Umezawa A
Stem Cell Res Ther; 2022 Mar; 13(1):104. PubMed ID: 35279203
[TBL] [Abstract][Full Text] [Related]
5. A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction.
Bulutoglu B; Rey-Bedón C; Mert S; Tian L; Jang YY; Yarmush ML; Usta OB
PLoS One; 2020; 15(2):e0229106. PubMed ID: 32106230
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte nuclear factor 6 activates the transcription of CYP3A4 in hepatocyte-like cells differentiated from human induced pluripotent stem cells.
Sasaki T; Takahashi S; Numata Y; Narita M; Tanaka Y; Kumagai T; Kondo Y; Matsunaga T; Ohmori S; Nagata K
Drug Metab Pharmacokinet; 2013; 28(3):250-9. PubMed ID: 23291635
[TBL] [Abstract][Full Text] [Related]
7. Efficient hepatocyte differentiation of primary human hepatocyte-derived organoids using three dimensional nanofibers (HYDROX) and their possible application in hepatotoxicity research.
Tong Y; Ueyama-Toba Y; Yokota J; Matsui H; Kanai M; Mizuguchi H
Sci Rep; 2024 May; 14(1):10846. PubMed ID: 38736008
[TBL] [Abstract][Full Text] [Related]
8. Exploration of components and mechanisms of Polygoni Multiflori Radix-induced hepatotoxicity using siRNA -mediated CYP3A4 or UGT1A1 knockdown liver cells.
Hu YH; Li DK; Quan ZY; Wang CY; Zhou M; Sun ZX
J Ethnopharmacol; 2021 Apr; 270():113845. PubMed ID: 33485974
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of expression of cytochrome P450 3A4 in a human liver epithelial cell line in differentiation-inducing conditions.
Yamazaki T; Tokiwa T
Hum Cell; 2021 May; 34(3):750-758. PubMed ID: 33495943
[TBL] [Abstract][Full Text] [Related]
10. Optimized protocol for induction of cytochrome P450 enzymes 1A2 and 3A4 in human primary-like hepatocyte cell strain HepaFH3 to study in vitro toxicology.
Kammerer S; Küpper JH
Clin Hemorheol Microcirc; 2018; 70(4):563-571. PubMed ID: 30347615
[TBL] [Abstract][Full Text] [Related]
11. Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol.
Chen YF; Tseng CY; Wang HW; Kuo HC; Yang VW; Lee OK
Hepatology; 2012 Apr; 55(4):1193-203. PubMed ID: 22095466
[TBL] [Abstract][Full Text] [Related]
12. Enrichment of high-functioning human iPS cell-derived hepatocyte-like cells for pharmaceutical research.
Takayama K; Hagihara Y; Toba Y; Sekiguchi K; Sakurai F; Mizuguchi H
Biomaterials; 2018 Apr; 161():24-32. PubMed ID: 29421559
[TBL] [Abstract][Full Text] [Related]
13. Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4.
Danek PJ; Basińska-Ziobroń A; Wójcikowski J; Daniel WA
Pharmacol Rep; 2021 Feb; 73(1):303-308. PubMed ID: 32888176
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach.
Zuo R; Li F; Parikh S; Cao L; Cooper KL; Hong Y; Liu J; Faris RA; Li D; Wang H
Drug Metab Dispos; 2017 Feb; 45(2):198-207. PubMed ID: 28062541
[TBL] [Abstract][Full Text] [Related]
15. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening.
Gómez-Lechón MJ; Tolosa L
Arch Toxicol; 2016 Sep; 90(9):2049-2061. PubMed ID: 27325232
[TBL] [Abstract][Full Text] [Related]
16. Morphological and Functional Characterization and Assessment of iPSC-Derived Hepatocytes for In Vitro Toxicity Testing.
Lu J; Einhorn S; Venkatarangan L; Miller M; Mann DA; Watkins PB; LeCluyse E
Toxicol Sci; 2015 Sep; 147(1):39-54. PubMed ID: 26092927
[TBL] [Abstract][Full Text] [Related]
17. A two-dimensional multiwell cell culture method for the production of CYP3A4-expressing hepatocyte-like cells from HepaRG cells.
Ooeda K; Kubiura-Ichimaru M; Tsuji S; Okuyama S; Yamashita M; Mine A; Kawamura F; Ueyama T; Tada M
Pharmacol Res Perspect; 2020 Oct; 8(5):e00652. PubMed ID: 32955797
[TBL] [Abstract][Full Text] [Related]
18. An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity.
Kondo Y; Iwao T; Nakamura K; Sasaki T; Takahashi S; Kamada N; Matsubara T; Gonzalez FJ; Akutsu H; Miyagawa Y; Okita H; Kiyokawa N; Toyoda M; Umezawa A; Nagata K; Matsunaga T; Ohmori S
Drug Metab Pharmacokinet; 2014; 29(3):237-43. PubMed ID: 24334537
[TBL] [Abstract][Full Text] [Related]
19. Application of Azamulin to Determine the Contribution of CYP3A4/5 to Drug Metabolic Clearance Using Human Hepatocytes.
Chanteux H; Rosa M; Delatour C; Nicolaï J; Gillent E; Dell'Aiera S; Ungell AL
Drug Metab Dispos; 2020 Sep; 48(9):778-787. PubMed ID: 32532738
[TBL] [Abstract][Full Text] [Related]
20. Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice.
Cheng J; Fang ZZ; Kim JH; Krausz KW; Tanaka N; Chiang JY; Gonzalez FJ
J Lipid Res; 2014 Mar; 55(3):455-65. PubMed ID: 24343899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
